Skip directly to Accessibility Notice

How to Purchase

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 11/12/19

  • 30-Day SEC Yield1

    1.58%
  • Total Net Assets

    $173.9M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.43%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly
  • Next Distribution Date

    12/27/2019

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    2,888,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.08%
  • Gross Expense Ratio

    0.43%
  • Fee Waivers and
    Expense Reimbursement

    -0.07%
  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2020. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 11/12/19

NAV/
Last Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
NAV
Chart
PPH $60.20
$60.16
68,332
19,389
$0.71 / +1.19%
$0.71 / +1.19%
+11.66%
+11.93%
$-0.04
-0.07%

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 4.66 3.63 9.93 0.14 6.62 0.62 -- 8.87
PPH (Share Price) 4.56 3.73 10.40 0.08 6.62 0.65 -- 9.01
MVPPHTR (Index) 4.66 3.64 9.36 0.00 6.58 0.62 -- 8.83
Performance Differential (NAV - Index) 0.00 -0.01 0.57 0.14 0.04 0.00 -- 0.04
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.99 -2.56 5.04 -9.88 1.59 -0.25 -- 8.34
PPH (Share Price) 0.99 -2.40 5.59 -9.77 1.62 -0.24 -- 8.49
MVPPHTR (Index) 1.01 -2.63 4.49 -10.02 1.56 -0.25 -- 8.29
Performance Differential (NAV - Index) -0.02 0.07 0.55 0.14 0.03 0.00 -- 0.05

Top 10 Holdings (%) as of 10/31/19 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
Abbvie Inc
ABBV US
126,652
10,075,167 5.59
Astrazeneca Plc
AZN US
204,199
10,011,877 5.56
Glaxosmithkline Plc
GSK US
215,615
9,875,167 5.48
Novo Nordisk A/S
NVO US
173,109
9,559,079 5.31
Sanofi
SNY US
202,183
9,316,593 5.17
Bristol-Myers Squibb Co
BMY US
160,866
9,228,882 5.12
Merck & Co Inc
MRK US
106,141
9,198,179 5.11
Pfizer Inc
PFE US
235,256
9,026,773 5.01
Eli Lilly & Co
LLY US
78,801
8,979,374 4.99
Johnson & Johnson
JNJ US
67,092
8,858,828 4.92
Top 10 Total (%) 52.26
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 10/31/19

  • Country

    % of Net Assets
  • United States

    61.25
  • United Kingdom

    12.68
  • Denmark

    5.31
  • France

    5.17
  • Switzerland

    4.81
  • Japan

    4.54
  • Israel

    3.74
  • Ireland

    2.59
  • Other/Cash

    -0.09

Sector Weightings (%) as of 10/31/19

  • Sector

    % of Net Assets
  • Health Care

    100.1
  • Other/Cash

    -0.1